AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Validity and Reliability of Mixed Reality-Based Functional Mobility Tests in Type 2 Diabetes

Recruitingn/aAges 18 Years - 65 YearsAllSelcuk University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Type 2 Diabetes Mellitus (T2DM) is a multifaceted metabolic disease associated not only with impaired glycemic control but also with reductions in muscle strength, balance, functional mobility, and walking performance. Individuals with T2DM may experience impairments in lower extremity function, postural control, and overall functional performance, which can negatively affect activities of daily living and quality of life. Therefore, the assessment of functional performance using reliable and valid methods is important for clinical monitoring and rehabilitation planning. The 6-Minute Walk Test (6MWT), Timed Up and Go Test (TUG), and Five-Repetition Sit-to-Stand Test (5xSTS) are widely used clinical assessments for evaluating walking capacity, functional mobility, lower extremity function, and physical performance in individuals with T2DM. Previous studies have demonstrated that these te

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Diagnosed with Type 2 Diabetes Mellitus by a physician, * Aged between 18 and 65 years, * Ability to ambulate independently without the use of an assistive device, * No participation in a structured exercise program within the previous 6 months, * Cognitive ability sufficient to understand and follow test instructions, * Visual, auditory, and vestibular functions sufficient to tolerate mixed reality applications, * Ability to read, understand, and follow instructions in Turkish, * Willingness to participate voluntarily in the study and provision of written informed consent. Exclusion Criteria: * Presence of proliferative diabetic retinopathy or severe non-proliferative diabetic retinopathy, * Advanced peripheral neuropathy, active foot ulcer, Charcot foot, or significant sensory loss that may compromise safe test performance, * Presence of peripheral arterial disease, * Advanced renal failure, requirement for dialysis, or nephropathy that may compromise exercise safety, * Myocardial infarction within the previous 6 months, * Unstable ischemic heart disease or uncontrolled angina, * Resting blood pressure greater than 160/100 mmHg, * Presence of severe musculoskeletal, neurological, or vestibular disorders that may interfere with safe test performance, * High risk of balance loss or spatial disorientation in the mixed reality environment due to visual, auditory, or balance impairments, * Cognitive, behavioral, or compliance-related problems that may prevent completion of the study procedures.
๐Ÿ’Š

What it tests

  • Mixed Reality-Based Functional Performance Assessment
๐Ÿ“

Where

1 site
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Konya, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy